Risk of colorectal cancer and adenomas in the families of patients with adenomas

A population-based study in Utah

Thérèse M F Tuohy, Kerry G. Rowe, Geraldine P. Mineau, Richard Pimentel, Randall W. Burt, Niloy Jewel Samadder

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

BACKGROUND Guidelines recommend that individuals with a first-degree relative (FDR) diagnosed with colorectal cancer (CRC) or advanced adenoma before age 60 years should undergo colonoscopy starting at age 40 years. The authors quantified the risk of adenomas and CRC in FDRs, second-degree relatives (SDRs), and third-degree relatives (TDRs) of patients diagnosed with adenomas and advanced adenomas. METHODS A population-based, retrospective, case-control study was performed of residents of the state of Utah aged 50 years to 80 years who underwent colonoscopy between 1995 and 2009 at Intermountain Healthcare or the University of Utah. Controls were selected from the population of colonoscopy patients who were free of adenomas or CRC and matched to each case based on sex and birth year. Colonoscopy results were linked with cancer and pedigree information from the Utah Population Database to investigate the familial aggregation of adenomas and CRC using Cox regression analysis. The unit of analysis was the relatives of cases and controls. RESULTS Of 126,936 patients who underwent colonoscopy, 43,189 had adenomas and 5563 had advanced adenomas and defined the case population. An elevated risk of CRC was found in FDRs (relative risk [RR], 1.35; 95% confidence interval [95% CI], 1.25-1.46), SDRs (RR, 1.15; 95% CI, 1.07-1.23) of adenoma cases, and in FDRs of advanced adenoma cases (RR, 1.68; 95% CI, 1.29-2.18) compared with controls. Approximately 10% of CRCs diagnosed in relatives would have been missed if the current screening guidelines were strictly adhered to. CONCLUSIONS Relatives of colonoscopy patients with adenomas and advanced adenomas appear to have a significantly elevated risk of developing colorectal neoplasia. These data should be considered when establishing CRC screening guidelines for individuals and their families. Cancer 2014;120:35-42.

Original languageEnglish (US)
Pages (from-to)35-42
Number of pages8
JournalCancer
Volume120
Issue number1
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Adenoma
Colorectal Neoplasms
Colonoscopy
Population
Guidelines
Confidence Intervals
Neoplasms
Pedigree
Early Detection of Cancer
Case-Control Studies
Regression Analysis
Parturition
Databases
Delivery of Health Care

Keywords

  • adenomatous polyps
  • colonoscopy
  • colorectal cancer
  • familial

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Risk of colorectal cancer and adenomas in the families of patients with adenomas : A population-based study in Utah. / Tuohy, Thérèse M F; Rowe, Kerry G.; Mineau, Geraldine P.; Pimentel, Richard; Burt, Randall W.; Samadder, Niloy Jewel.

In: Cancer, Vol. 120, No. 1, 01.01.2014, p. 35-42.

Research output: Contribution to journalArticle

Tuohy, Thérèse M F ; Rowe, Kerry G. ; Mineau, Geraldine P. ; Pimentel, Richard ; Burt, Randall W. ; Samadder, Niloy Jewel. / Risk of colorectal cancer and adenomas in the families of patients with adenomas : A population-based study in Utah. In: Cancer. 2014 ; Vol. 120, No. 1. pp. 35-42.
@article{5c0451d8e5bd47e7981a84d9816970f3,
title = "Risk of colorectal cancer and adenomas in the families of patients with adenomas: A population-based study in Utah",
abstract = "BACKGROUND Guidelines recommend that individuals with a first-degree relative (FDR) diagnosed with colorectal cancer (CRC) or advanced adenoma before age 60 years should undergo colonoscopy starting at age 40 years. The authors quantified the risk of adenomas and CRC in FDRs, second-degree relatives (SDRs), and third-degree relatives (TDRs) of patients diagnosed with adenomas and advanced adenomas. METHODS A population-based, retrospective, case-control study was performed of residents of the state of Utah aged 50 years to 80 years who underwent colonoscopy between 1995 and 2009 at Intermountain Healthcare or the University of Utah. Controls were selected from the population of colonoscopy patients who were free of adenomas or CRC and matched to each case based on sex and birth year. Colonoscopy results were linked with cancer and pedigree information from the Utah Population Database to investigate the familial aggregation of adenomas and CRC using Cox regression analysis. The unit of analysis was the relatives of cases and controls. RESULTS Of 126,936 patients who underwent colonoscopy, 43,189 had adenomas and 5563 had advanced adenomas and defined the case population. An elevated risk of CRC was found in FDRs (relative risk [RR], 1.35; 95{\%} confidence interval [95{\%} CI], 1.25-1.46), SDRs (RR, 1.15; 95{\%} CI, 1.07-1.23) of adenoma cases, and in FDRs of advanced adenoma cases (RR, 1.68; 95{\%} CI, 1.29-2.18) compared with controls. Approximately 10{\%} of CRCs diagnosed in relatives would have been missed if the current screening guidelines were strictly adhered to. CONCLUSIONS Relatives of colonoscopy patients with adenomas and advanced adenomas appear to have a significantly elevated risk of developing colorectal neoplasia. These data should be considered when establishing CRC screening guidelines for individuals and their families. Cancer 2014;120:35-42.",
keywords = "adenomatous polyps, colonoscopy, colorectal cancer, familial",
author = "Tuohy, {Th{\'e}r{\`e}se M F} and Rowe, {Kerry G.} and Mineau, {Geraldine P.} and Richard Pimentel and Burt, {Randall W.} and Samadder, {Niloy Jewel}",
year = "2014",
month = "1",
day = "1",
doi = "10.1002/cncr.28227",
language = "English (US)",
volume = "120",
pages = "35--42",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Risk of colorectal cancer and adenomas in the families of patients with adenomas

T2 - A population-based study in Utah

AU - Tuohy, Thérèse M F

AU - Rowe, Kerry G.

AU - Mineau, Geraldine P.

AU - Pimentel, Richard

AU - Burt, Randall W.

AU - Samadder, Niloy Jewel

PY - 2014/1/1

Y1 - 2014/1/1

N2 - BACKGROUND Guidelines recommend that individuals with a first-degree relative (FDR) diagnosed with colorectal cancer (CRC) or advanced adenoma before age 60 years should undergo colonoscopy starting at age 40 years. The authors quantified the risk of adenomas and CRC in FDRs, second-degree relatives (SDRs), and third-degree relatives (TDRs) of patients diagnosed with adenomas and advanced adenomas. METHODS A population-based, retrospective, case-control study was performed of residents of the state of Utah aged 50 years to 80 years who underwent colonoscopy between 1995 and 2009 at Intermountain Healthcare or the University of Utah. Controls were selected from the population of colonoscopy patients who were free of adenomas or CRC and matched to each case based on sex and birth year. Colonoscopy results were linked with cancer and pedigree information from the Utah Population Database to investigate the familial aggregation of adenomas and CRC using Cox regression analysis. The unit of analysis was the relatives of cases and controls. RESULTS Of 126,936 patients who underwent colonoscopy, 43,189 had adenomas and 5563 had advanced adenomas and defined the case population. An elevated risk of CRC was found in FDRs (relative risk [RR], 1.35; 95% confidence interval [95% CI], 1.25-1.46), SDRs (RR, 1.15; 95% CI, 1.07-1.23) of adenoma cases, and in FDRs of advanced adenoma cases (RR, 1.68; 95% CI, 1.29-2.18) compared with controls. Approximately 10% of CRCs diagnosed in relatives would have been missed if the current screening guidelines were strictly adhered to. CONCLUSIONS Relatives of colonoscopy patients with adenomas and advanced adenomas appear to have a significantly elevated risk of developing colorectal neoplasia. These data should be considered when establishing CRC screening guidelines for individuals and their families. Cancer 2014;120:35-42.

AB - BACKGROUND Guidelines recommend that individuals with a first-degree relative (FDR) diagnosed with colorectal cancer (CRC) or advanced adenoma before age 60 years should undergo colonoscopy starting at age 40 years. The authors quantified the risk of adenomas and CRC in FDRs, second-degree relatives (SDRs), and third-degree relatives (TDRs) of patients diagnosed with adenomas and advanced adenomas. METHODS A population-based, retrospective, case-control study was performed of residents of the state of Utah aged 50 years to 80 years who underwent colonoscopy between 1995 and 2009 at Intermountain Healthcare or the University of Utah. Controls were selected from the population of colonoscopy patients who were free of adenomas or CRC and matched to each case based on sex and birth year. Colonoscopy results were linked with cancer and pedigree information from the Utah Population Database to investigate the familial aggregation of adenomas and CRC using Cox regression analysis. The unit of analysis was the relatives of cases and controls. RESULTS Of 126,936 patients who underwent colonoscopy, 43,189 had adenomas and 5563 had advanced adenomas and defined the case population. An elevated risk of CRC was found in FDRs (relative risk [RR], 1.35; 95% confidence interval [95% CI], 1.25-1.46), SDRs (RR, 1.15; 95% CI, 1.07-1.23) of adenoma cases, and in FDRs of advanced adenoma cases (RR, 1.68; 95% CI, 1.29-2.18) compared with controls. Approximately 10% of CRCs diagnosed in relatives would have been missed if the current screening guidelines were strictly adhered to. CONCLUSIONS Relatives of colonoscopy patients with adenomas and advanced adenomas appear to have a significantly elevated risk of developing colorectal neoplasia. These data should be considered when establishing CRC screening guidelines for individuals and their families. Cancer 2014;120:35-42.

KW - adenomatous polyps

KW - colonoscopy

KW - colorectal cancer

KW - familial

UR - http://www.scopus.com/inward/record.url?scp=84890787434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890787434&partnerID=8YFLogxK

U2 - 10.1002/cncr.28227

DO - 10.1002/cncr.28227

M3 - Article

VL - 120

SP - 35

EP - 42

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 1

ER -